Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    90.00 (2.45%)
Bid:
3,744.00
Ask:
3,748.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

11 Nov 2025 07:00

RNS Number : 9353G
4imprint Group PLC
11 November 2025
 

 

 

11 November 2025

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

4imprint today provides a scheduled update on the Group's trading and operations.

 

The Group has delivered a resilient operational and financial performance against the backdrop of volatile macroeconomic conditions in the 10-month period up to the end of October 2025.

 

The Board expects full year Group revenue of not less than $1.32bn, which is at the high end of the current analyst forecast range, and profit before tax of not less than $142m, which is above the upper end of the current analyst forecast range.

 

Group revenue for the first 10 months of 2025 was 2% below the same period in 2024. Order intake has continued to run approximately 3% below prior year with average order values in line with prior year, as the business has traded resiliently through its peak seasonal months. Existing customer order count was flat year to date, reflecting strong and consistent retention rates. New customer order count was down 13% year to date, a continuation of the performance seen in the first half.

 

Gross profit margin has remained strong at just below 33%, as product cost increases due to tariffs are being phased in later than anticipated, while the marketing mix is providing the flexibility we anticipated. As a result, a double-digit operating profit margin has been maintained in the 10-month period.

 

The Group remains highly cash generative and well financed, with a cash balance of $124m at the end of October 2025. The Board has approved a c.$10m capital expenditure for the relocation of its leased downtown Oshkosh, Wisconsin office space to its recently expanded distribution centre which is expected to be completed in mid-2026.

 

The Board is confident that the Group will continue to effectively navigate market conditions, delivering solid financial results while positioning the business to take advantage of opportunities that will present themselves as economic and market conditions improve.

 

For further information, please contact:

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

 

MHP Group

Tel. + 44 (0) 7884 494112

Kevin Lyons-Tarr, Chief Executive Officer

Michelle Brukwicki, Chief Financial Officer

Katie Hunt

Eleni Menikou

Steve Bindas, Director of Investor Relations

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQBLFFEFLZFBK
Date   Source Headline
16th Mar 20217:00 amRNSFinal Results
10th Mar 20213:49 pmRNSDirector Declaration
25th Feb 20217:00 amRNSDirectorate Change
12th Feb 20218:56 amRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update and Notice of Final Results
14th Dec 20204:33 pmRNSDirector/PDMR Shareholding
14th Dec 20202:35 pmRNSEBT Purchase
7th Dec 202012:43 pmRNSEBT Purchase
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
30th Oct 20207:00 amRNSUpdate on Current Trading
28th Oct 20204:35 pmRNSHolding(s) in Company
28th Oct 20204:00 pmRNSHolding(s) in Company
27th Oct 20208:32 amRNSEBT Purchase
15th Oct 20203:59 pmRNSEBT Purchase
6th Oct 202012:48 pmRNSDirector/PDMR Shareholding
5th Oct 20203:22 pmRNSEBT Purchase
11th Sep 202010:24 amEQSEdison Investment Research Limited: Edison issues outlook on 4imprint Group (FOUR)
25th Aug 20205:34 pmRNSHolding(s) in Company
13th Aug 20207:00 amRNSHalf-year Report
6th Aug 202012:02 pmRNSPrice Monitoring Extension
23rd Jun 20203:51 pmRNSHolding(s) in Company
22nd Jun 202012:08 pmRNSSecond Price Monitoring Extn
22nd Jun 202012:03 pmRNSPrice Monitoring Extension
18th Jun 202012:02 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSUpdate on Current Trading
22nd May 20203:34 pmRNSDirector/PDMR Shareholding
22nd May 20202:01 pmRNSDirector/PDMR Shareholding
13th May 20209:10 amRNSHolding(s) in Company
5th May 20201:59 pmRNSResult of AGM
27th Apr 20201:45 pmRNSDisclosure of rights attached to equity shares
24th Apr 20209:06 amRNS2020 AGM - Change of Arrangements
22nd Apr 202012:07 pmRNSSecond Price Monitoring Extn
22nd Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 20203:46 pmRNSHolding(s) in Company
17th Apr 202012:07 pmRNSSecond Price Monitoring Extn
17th Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20208:21 amRNSHolding(s) in Company
15th Apr 202012:08 pmRNSSecond Price Monitoring Extn
15th Apr 202012:03 pmRNSPrice Monitoring Extension
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:35 pmRNSPrice Monitoring Extension
9th Apr 20203:55 pmRNSHolding(s) in Company
8th Apr 20202:16 pmRNSHolding(s) in Company
7th Apr 20203:33 pmRNSHolding(s) in Company
7th Apr 202012:02 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSCoronavirus (COVID-19): Update
6th Apr 20209:12 amRNSEBT Purchase
3rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
3rd Apr 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.